Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

The five principal biomarker comparisons (vitamin C, 25(OH)D, lactate, albumin, and the LAR), which correspond to the study objectives, were defined as the family of comparisons for multiplicity control; all other comparisons were exploratory.

Source: 2.6. Statistical Analysis. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Plasma Vitamin C, 25-Hydroxyvitamin D, and the Lactate-to-Albumin Ratio at PICU Admission in Survivors and Non-Survivors of Phoenix-Defined Pediatric Sepsis and Septic Shock: An Exploratory Prospective Cohort Study

Source: Article title.

We enrolled consecutive children aged 1 month to 17 years with suspected infection and a Phoenix Sepsis Score of at least 2; septic shock required at least one cardiovascular point.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Plasma Vitamin C, 25-Hydroxyvitamin D, and the Lactate-to-Albumin Ratio at PICU Admission in Survivors and Non-Survivors of Phoenix-Defined Pediatric Sepsis and Septic Shock: An Exploratory Prospective Cohort Study

Cohort study · Pediatric Reports · 2026

Original publication title

Plasma Vitamin C, 25-Hydroxyvitamin D, and the Lactate-to-Albumin Ratio at PICU Admission in Survivors and Non-Survivors of Phoenix-Defined Pediatric Sepsis and Septic Shock: An Exploratory Prospective Cohort Study

Jesús J. Martínez-García; Adrian Canizalez-Román; Ricardo Zatarain-Lopez; Marcel Antonio Cazarez-Aguilar; Martín Adrián Bolívar-Rodríguez; Luis Velazquez-Lopez; Carlos Alberto Osuna-Ramirez; Manuel A. Correa-Flores; Maria Fernanda Garcia-de Leon; Erika Acosta-Smith; Jorge Velazquez-Roman; Hector Flores-Villaseñor; Uriel A. Angulo-Zamudio; Nidia León-Sicairos

© 2026 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Background: Vitamin C, 25-hydroxyvitamin D (25[OH]D), and the lactate-to-albumin ratio (LAR) have been proposed as prognostic markers in sepsis. However, pediatric data are limited, and these markers have not been evaluated together in a cohort classified according to the Phoenix criteria. We quantified these markers at pediatric intensive care unit (PICU) admission and assessed their unadjusted association with mortality. Methods: This single-center prospective cohort study followed the STROBE statement. We enrolled consecutive children aged 1 month to 17 years with suspected infection and a Phoenix Sepsis Score of at least 2; septic shock required at least one cardiovascular point.

Blood was sampled within 1 h of admission. We analyzed ascorbate by ultra-high-performance liquid chromatography coupled with mass spectrometry in light-protected heparin plasma. The endpoint was pre-discharge PICU mortality. We expressed differences as Hodges: Lehmann estimates with exact 95% confidence intervals (CIs), and discrimination as the area under the receiver operating characteristic curve (AUC). The five principal biomarker comparisons were subjected to Benjamini: Hochberg false discovery rate (FDR) control. We fitted no multivariable model (11 events). Results: Of the 37 children enrolled, 33 (89.2%) had septic shock, and the mortality rate was 29.7%.

Non-survivors had lower plasma vitamin C concentrations (51.1 vs. 73.8 umol/L; difference −17.0, 95% CI −28.4 to −5.7, p = 0.028, q = 0.141, AUC 0.73, 95% CI 0.55 to 0.90), and mortality declined across ascending vitamin C tertiles, although the gradient was not statistically significant (p = 0.058). No patient had hypovitaminosis C (<23 umol/L). We did not detect an association between 25(OH)D, lactate, albumin, or the LAR and mortality (all p ≥ 0.18; AUC 0.50 to 0.64), and the LAR was collinear with lactate (rho = 0.95).

The weight-for-age z-score correlated with vitamin C (rho = 0.39, p = 0.033). Conclusions: In this small cohort, non-survivors had lower plasma vitamin C concentrations within the replete range in unadjusted analysis; this difference did not persist after FDR control or in the subgroup with evaluable nutritional status, and nutritional confounding cannot be excluded. No association with mortality was detected for 25(OH)D, lactate, albumin, or the LAR. These findings are hypothesis-generating, do not establish prognostic value, and require multicenter confirmation.

Authors’ abstract

Background: Vitamin C, 25-hydroxyvitamin D (25[OH]D), and the lactate-to-albumin ratio (LAR) have been proposed as prognostic markers in sepsis. However, pediatric data are limited, and these markers have not been evaluated together in a cohort classified according to the Phoenix criteria. We quantified these markers at pediatric intensive care unit (PICU) admission and assessed their unadjusted association with mortality. Methods: This single-center prospective cohort study followed the STROBE statement. We enrolled consecutive children aged 1 month to 17 years with suspected infection and a Phoenix Sepsis Score of at least 2; septic shock required at least one cardiovascular point.

Blood was sampled within 1 h of admission. We analyzed ascorbate by ultra-high-performance liquid chromatography coupled with mass spectrometry in light-protected heparin plasma. The endpoint was pre-discharge PICU mortality. We expressed differences as Hodges: Lehmann estimates with exact 95% confidence intervals (CIs), and discrimination as the area under the receiver operating characteristic curve (AUC). The five principal biomarker comparisons were subjected to Benjamini: Hochberg false discovery rate (FDR) control. We fitted no multivariable model (11 events). Results: Of the 37 children enrolled, 33 (89.2%) had septic shock, and the mortality rate was 29.7%.

Non-survivors had lower plasma vitamin C concentrations (51.1 vs. 73.8 umol/L; difference −17.0, 95% CI −28.4 to −5.7, p = 0.028, q = 0.141, AUC 0.73, 95% CI 0.55 to 0.90), and mortality declined across ascending vitamin C tertiles, although the gradient was not statistically significant (p = 0.058). No patient had hypovitaminosis C (<23 umol/L). We did not detect an association between 25(OH)D, lactate, albumin, or the LAR and mortality (all p ≥ 0.18; AUC 0.50 to 0.64), and the LAR was collinear with lactate (rho = 0.95).

The weight-for-age z-score correlated with vitamin C (rho = 0.39, p = 0.033). Conclusions: In this small cohort, non-survivors had lower plasma vitamin C concentrations within the replete range in unadjusted analysis; this difference did not persist after FDR control or in the subgroup with evaluable nutritional status, and nutritional confounding cannot be excluded. No association with mortality was detected for 25(OH)D, lactate, albumin, or the LAR. These findings are hypothesis-generating, do not establish prognostic value, and require multicenter confirmation.

Publication and source details

Original title: Plasma Vitamin C, 25-Hydroxyvitamin D, and the Lactate-to-Albumin Ratio at PICU Admission in Survivors and Non-Survivors of Phoenix-Defined Pediatric Sepsis and Septic Shock: An Exploratory Prospective Cohort Study

Jesús J. Martínez-García; Adrian Canizalez-Román; Ricardo Zatarain-Lopez; Marcel Antonio Cazarez-Aguilar; Martín Adrián Bolívar-Rodríguez; Luis Velazquez-Lopez; Carlos Alberto Osuna-Ramirez; Manuel A. Correa-Flores; Maria Fernanda Garcia-de Leon; Erika Acosta-Smith; Jorge Velazquez-Roman; Hector Flores-Villaseñor; Uriel A. Angulo-Zamudio; Nidia León-Sicairos

Pediatric Reports · 2026

* Correspondence: canizalez@uas.edu.mx (A.C.-R.); nidialeon@uas.edu.mx (N.L.-S.); Tel.: +52-6677538802 (A.C.-R.); Fax: +52-6677538801 (N.L.-S.)© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.This research received no external funding.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-07T21:02:41+00:00

DOI: 10.3390/pediatric18050132 · PMC13708177